Sandbox RSGFire

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farman Khan, MD, MRCP [2]; Mohamed Moubarak, M.D. [3]; Rim Halaby, M.D. [4]

Infective endocarditis Resident Survival Guide Microchapters
Overview
Causes
FIRE
Diagnosis
Treatment
Prophylaxis
Do's
Don'ts

Overview

Infective endocarditis is the infection of the endothelium of the heart including but not limited to the valves. While acute bacterial endocarditis is caused by an infection with a virulent organism such as staphylococcus aureus, group A or other beta-hemolytic streptococci, subacute bacterial endocarditis is an indolent infection with less virulent organisms like streptococcus viridans. Patients with unexplained fever for more than 48 hours and who are at high risk for infective endocarditis and patients among whom valve regurgitation is newly diagnosed should undergo a diagnostic workup to rule out endocarditis. The diagnosis of endocarditis depends on a thorough history and physical exam as well as on the results of the blood cultures and the findings on transthoracic echocardiogram or transesophageal echocardiogram. The modified Duke criteria is used to establish the diagnosis of endocarditis. Endocarditis is initially treated with empiric antibiotic therapy until the causative agent is identified.[1][2]

Causes

Life Threatening Causes

Acute endocarditis is a life-threatening condition and must be treated as such irrespective of the underlying cause.

Common Causes

FIRE:Focused Initial Rapid Evaluation

A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.[1][3]

Boxes in salmon color signify that an urgent management is needed.

Abbreviations: CT: Computed tomography ; CTA: Computed tomography angiography; MRA: Magnetic resonance angiography; MRI: Magnetic resonance imaging; TEE: Transesophageal echocardiography; TTE: Transthoracic echocardiography

Antibiotic Prophylaxis

Shown below is a table depicting the prophylaxis antibiotic regimes for infective endocarditis.[1]

Infective Endocarditis Antibiotic Prophylaxis
Oral treatment is tolerated
Not allergic to penicillin Allergic to penicillin
Amoxicillin 2 g Ampicillin 2 g IM or IV
OR
Cefazolin 1 g IM or IV
OR
Ceftriaxone 1 g IM or IV
Oral treatment is not tolerated
Not allergic to penicillin Allergic to penicillin
Cefalexin 2 g
OR
Clindamycin 600 mg
OR
Azithromycin 500 mg
OR
Clarithromycin 500 mg
Cefazolin 1 g IM or IV
OR
Ceftriaxone 1 g IM or IV
OR
Clindamycin 600 mg IM or IV

Do's

  • If HACEK bacteremia is detected without any focus of infection, suspect the presence of infective endocarditis even in the absence of the typical signs and symptoms.[2]

Don'ts

  • Do not administer infective endocarditis prophylaxis for the following dental procedures:
    • Anesthetic injections in noninfected tissue
    • Dental radiographs
    • Shedding of deciduous teeth
    • Placement of orthodontic brackets
    • Placement or removal of prosthodontic or orthodontic appliances
    • Adjustment of orthodontic appliances
    • Bleeding following trauma to the oral mucosa or lips[4]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary". Retrieved 4 March 2014.
  2. 2.0 2.1 2.2 Baddour, LM.; Wilson, WR.; Bayer, AS.; Fowler, VG.; Bolger, AF.; Levison, ME.; Ferrieri, P.; Gerber, MA.; Tani, LY. (2005). "Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America". Circulation. 111 (23): e394–434. doi:10.1161/CIRCULATIONAHA.105.165564. PMID 15956145. Unknown parameter |month= ignored (help)
  3. 3.0 3.1 Weinstein L (1986). "Life-threatening complications of infective endocarditis and their management". Arch Intern Med. 146 (5): 953–7. PMID 3516105.
  4. 4.0 4.1 Bonow RO, Carabello BA, Chatterjee K; et al. (2008). "2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–661. doi:10.1161/CIRCULATIONAHA.108.190748. PMID 18820172. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources